Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
VivoSim Labs, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
VIVS
Nasdaq
2836
vivosim.ai
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for VivoSim Labs, Inc.
VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testing
- Apr 28th, 2026 6:05 am
VivoSim Announces Pricing of up to a $4 Million Public Offering
- Apr 1st, 2026 6:05 am
VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs
- Mar 24th, 2026 6:05 am
VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales
- Mar 3rd, 2026 6:05 am
VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego
- Feb 11th, 2026 6:05 am
NIO Inc. Announces Profit Alert for the Fourth Quarter of 2025
- Feb 5th, 2026 3:00 am
NIO January Deliveries Nearly Double Year On Year
- Feb 2nd, 2026 4:59 am
NIO Inc. Provides January 2026 Delivery Update
- Feb 1st, 2026 1:00 am
Top Midday Gainers
- Jan 30th, 2026 11:48 am
BC-Most Active Stocks
- Jan 30th, 2026 8:30 am
Wall Street Set to Open Lower Friday as Investors React to Trump's Choice of Warsh as Fed Chair
- Jan 30th, 2026 7:14 am
VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China
- Jan 29th, 2026 2:05 pm
Rivian vs. NIO: Which EV Manufacturer Stock Is Worth Buying?
- Jan 28th, 2026 8:40 am
VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer
- Jan 6th, 2026 6:05 am
Did Record 2025 Deliveries and a Multi‑Brand EV Push Just Shift NIO's (NIO) Investment Narrative?
- Jan 5th, 2026 3:11 pm
The Zacks Analyst Blog NIO, XPeng and Li Auto
- Jan 5th, 2026 6:36 am
NIO, XPeng & Li Auto Report December & Fourth-Quarter Delivery Results
- Jan 2nd, 2026 8:41 am
NIO Posts Record December and Q4 Deliveries as 2025 Volumes Surge
- Jan 2nd, 2026 5:03 am
How Investors Are Reacting To NIO (NIO) Surging November Deliveries Across Its Multi‑Brand EV Lineup
- Dec 13th, 2025 12:06 pm
Nio Stock Slumps After Surprise November Delivery Drop
- Dec 1st, 2025 8:52 am
Scroll